Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
Wei Zheng, Yanling Zhou, Chengyu Wang, et al.
PeerJ (2021) Vol. 9, pp. e10989-e10989
Open Access | Times Cited: 14

Showing 14 citing articles:

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
Anna Mosiołek, Jadwiga Mosiołek, Sławomir Jakima, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 15, pp. 3377-3377
Open Access | Times Cited: 57
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Gustavo C. Medeiros, Todd D. Gould, William L. Prueitt, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3658-3669
Open Access | Times Cited: 40
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Matea Nikolac Perković, Martin Gredičak, Marina Šagud, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 283-296
Closed Access | Times Cited: 11
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Jian-Qiang Tan, Li-Mei Gu, Yanling Zhou, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Molecular Regulation and Therapeutic Applications of Brain-Derived Neurotrophic Factor–Tropomyosin-Related Kinase B Signaling in Major Depressive Disorder Though Its Interaction with Vascular Endothelial Growth Factor and N-Methyl-D-Aspartic Acid Receptors: A Narrative Review
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Neuroplasticity and Psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models
Claudio Agnorelli, Meg J. Spriggs, Kate Godfrey, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106132-106132
Open Access
Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis
Abigail E. Calder, Adrian Hase, Gregor Hasler
Molecular Psychiatry (2024)
Open Access | Times Cited: 3
Various BDNF administrations attenuate SPS-induced anxiety-like behaviors
Jun-Bin Yin, Haixia Liu, Wei Shi, et al.
Neuroscience Letters (2022) Vol. 788, pp. 136851-136851
Closed Access | Times Cited: 14
The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality
Yanling Zhou, Chengyu Wang, Xiaofeng Lan, et al.
Journal of Psychiatric Research (2021) Vol. 144, pp. 312-319
Closed Access | Times Cited: 17
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
Giordano Novak Rossi, Jaime E. C. Hallak, Glen B. Baker, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 1, pp. 129-155
Closed Access | Times Cited: 10
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
Wei Zheng, Li-Mei Gu, Yanling Zhou, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 4, pp. 1013-1021
Open Access | Times Cited: 9
The Clinician Scientist Training Program in Iran: Catalyzing Clinical Science Advancements
Sophia Esalatmanesh, Ladan Kashani, Shahin Akhondzadeh
Avicenna Journal of Medical Biotechnology (2023)
Open Access | Times Cited: 4
Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials
Mu‐Hong Chen, Hui-Ju Wu, Cheng‐Ta Li, et al.
Journal of Psychiatric Research (2021) Vol. 144, pp. 448-454
Closed Access | Times Cited: 4
Associação entre o fator neurotrófico derivado do encéfalo (BDNF) e o transtorno depressivo: uma revisão de literatura
Thayná Bertolini dos Santos, Vytor Hugo Staut de Souza, Noéli Cristina Gouveia Lopes, et al.
Research Society and Development (2021) Vol. 10, Iss. 10, pp. e461101019139-e461101019139
Open Access | Times Cited: 2
Page 1

Scroll to top